genekam logo
  • usa
    • german
    • russia
    • china
Duissern Str. 65a · 47058 Duisburg · Germany
Tel. +49 203 / 555858-31,-32,-33 · Fax: +49 203 / 35 82 99
menuicon
slider
Latest News:

08.08.2018
Genekam is working on potential therapeutic molecules and antibodies against pandemic influenza viruses

Latest News:

13.06.2018
3D Genomemedicine Inc is going to operate in USA

  • BIO 2018

    Visit us at BIO 2019 in Philadelphia, USA:
    03.06. - 06.06 2019

  • MEDICA 2018

    Visit us at MEDICA, Hall 3 Booth 3F05 in Duesseldorf, Germany:
    12.11.18 - 15.11.18

  • BIO Investor Forum

    Visit us at BIO Investor Forum in San Francisco, USA:
    16.10. - 18.10 2018

  • BIO 2018

    Visit us at BIO 2019 in Philadelphia, USA:
    03.06. - 06.06 2019

  • MEDICA 2018

    Visit us at MEDICA, Hall 3 Booth 3F05 in Duesseldorf, Germany:
    12.11.18 - 15.11.18

  • BIO Investor Forum

    Visit us at BIO Investor Forum in San Francisco, USA:
    16.10. - 18.10 2018

Antibody Conjugate Therapy

Genekam is developing complex solutions based on antibody conjugates for therapeutic and diagnostic use. The antibodies can be recombinant as well as monoclonal type. Conjugates will be based on beyond the state of art technology. Some of conjugates may have potential to be used as vaccines also.

TOP